• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管生成拟态在癌变发生中的作用及其临床应用

Vasculogenic mimicry in carcinogenesis and clinical applications.

机构信息

Department of Thoracic Surgery, Xiangya Hospital, Central South University, Xiangya Road 87th, Changsha, 410008, Hunan, People's Republic of China.

Department of Oncology, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, People's Republic of China.

出版信息

J Hematol Oncol. 2020 Mar 14;13(1):19. doi: 10.1186/s13045-020-00858-6.

DOI:10.1186/s13045-020-00858-6
PMID:32169087
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7071697/
Abstract

Distinct from classical tumor angiogenesis, vasculogenic mimicry (VM) provides a blood supply for tumor cells independent of endothelial cells. VM has two distinct types, namely tubular type and patterned matrix type. VM is associated with high tumor grade, tumor progression, invasion, metastasis, and poor prognosis in patients with malignant tumors. Herein, we discuss the recent studies on the role of VM in tumor progression and the diverse mechanisms and signaling pathways that regulate VM in tumors. Furthermore, we also summarize the latest findings of non-coding RNAs, such as lncRNAs and miRNAs in VM formation. In addition, we review application of molecular imaging technologies in detection of VM in malignant tumors. Increasing evidence suggests that VM is significantly associated with poor overall survival in patients with malignant tumors and could be a potential therapeutic target.

摘要

与经典的肿瘤血管生成不同,脉管生成拟态(VM)为肿瘤细胞提供了一种独立于内皮细胞的血液供应。VM 有两种不同的类型,即管状型和图案基质型。VM 与恶性肿瘤患者的高肿瘤分级、肿瘤进展、侵袭、转移和预后不良有关。在此,我们讨论了 VM 在肿瘤进展中的作用以及调节肿瘤中 VM 的多种机制和信号通路的最新研究。此外,我们还总结了非编码 RNA(如 lncRNA 和 miRNA)在 VM 形成中的最新发现。此外,我们回顾了分子成像技术在检测恶性肿瘤中 VM 的应用。越来越多的证据表明,VM 与恶性肿瘤患者的总体生存率显著相关,可能是一个潜在的治疗靶点。

相似文献

1
Vasculogenic mimicry in carcinogenesis and clinical applications.血管生成拟态在癌变发生中的作用及其临床应用
J Hematol Oncol. 2020 Mar 14;13(1):19. doi: 10.1186/s13045-020-00858-6.
2
Expression profiling of long noncoding RNAs associated with vasculogenic mimicry in osteosarcoma.骨肿瘤中与血管生成拟态相关的长非编码 RNA 的表达谱分析。
J Cell Biochem. 2019 Aug;120(8):12473-12488. doi: 10.1002/jcb.28514. Epub 2019 Mar 1.
3
The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment.肿瘤治疗中血管生成拟态相关的缺氧信号通路。
Biomed Pharmacother. 2016 May;80:127-135. doi: 10.1016/j.biopha.2016.03.010. Epub 2016 Mar 21.
4
Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy.靶向植物化学物质的血管生成拟态:癌症治疗的潜在机会。
IUBMB Life. 2020 May;72(5):825-841. doi: 10.1002/iub.2233. Epub 2020 Feb 6.
5
Long noncoding RNA n339260 promotes vasculogenic mimicry and cancer stem cell development in hepatocellular carcinoma.长链非编码 RNA n339260 促进肝癌中的血管生成拟态和癌症干细胞发展。
Cancer Sci. 2018 Oct;109(10):3197-3208. doi: 10.1111/cas.13740. Epub 2018 Aug 14.
6
Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.长链非编码 RNA TP73-AS1 的敲低通过靶向 miR-490-3p/TWIST1 轴抑制三阴性乳腺癌细胞血管生成拟态。
Biochem Biophys Res Commun. 2018 Oct 12;504(4):629-634. doi: 10.1016/j.bbrc.2018.08.122. Epub 2018 Sep 5.
7
Signaling pathways in tumor vasculogenic mimicry.肿瘤血管生成拟态中的信号通路。
Biochemistry (Mosc). 2012 Sep;77(9):1044-55. doi: 10.1134/S000629791209012X.
8
Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.缺氧肿瘤微环境中的血管生成拟态机制。
Mol Cancer. 2021 Jan 4;20(1):7. doi: 10.1186/s12943-020-01288-1.
9
Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors.上皮-内皮转化与癌症干细胞:恶性肿瘤中血管生成拟态的两大基石。
Oncotarget. 2017 May 2;8(18):30502-30510. doi: 10.18632/oncotarget.8461.
10
Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma.血管生成拟态在肝细胞癌中的调控机制及治疗靶点。
Pharmacol Res. 2021 Apr;166:105507. doi: 10.1016/j.phrs.2021.105507. Epub 2021 Feb 18.

引用本文的文献

1
CD93 in Health and Disease: Bridging Physiological Functions and Clinical Applications.健康与疾病中的CD93:连接生理功能与临床应用
Int J Mol Sci. 2025 Sep 4;26(17):8617. doi: 10.3390/ijms26178617.
2
Inhibition of PI3K and Hedgehog Signaling Pathway Inhibits Hypoxia-Induced Vasculogenic Mimicry Formation in Ovarian Cancer Stem Cells.抑制PI3K和Hedgehog信号通路可抑制缺氧诱导的卵巢癌干细胞中血管生成拟态的形成。
Balkan Med J. 2025 Sep 1;42(5):440-451. doi: 10.4274/balkanmedj.galenos.2025.2025-7-262.
3
SPANXB1 drives brain metastasis in breast cancer via MMP1 regulation: potential therapeutic insights with metformin.

本文引用的文献

1
Anti-angiogenesis Potential of Phytochemicals for the Therapeutic Management of Tumors.植物化学物质的抗血管生成潜力及其在肿瘤治疗管理中的应用。
Curr Pharm Des. 2020;26(2):265-278. doi: 10.2174/1381612826666191230142638.
2
FKBPL-based peptide, ALM201, targets angiogenesis and cancer stem cells in ovarian cancer.基于 FKBPL 的肽类药物 ALM201 靶向卵巢癌中的血管生成和癌症干细胞。
Br J Cancer. 2020 Feb;122(3):361-371. doi: 10.1038/s41416-019-0649-5. Epub 2019 Nov 27.
3
Mechanisms of Vasculogenic Mimicry in Ovarian Cancer.卵巢癌中血管生成拟态的机制
SPANXB1通过基质金属蛋白酶1调控驱动乳腺癌脑转移:二甲双胍的潜在治疗启示
Cell Death Discov. 2025 Aug 30;11(1):418. doi: 10.1038/s41420-025-02721-4.
4
Expression patterns and clinical significance of vasculogenic mimicry-related genes in patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者中血管生成拟态相关基因的表达模式及临床意义
Front Immunol. 2025 Aug 13;16:1614203. doi: 10.3389/fimmu.2025.1614203. eCollection 2025.
5
A SORT1/EGFR molecular interplay as a prognostic biomarker in glioblastoma vasculogenic mimicry: implications in the transcriptional regulation of cancer stemness and drug resistance.一种作为胶质母细胞瘤血管生成拟态预后生物标志物的SORT1/EGFR分子相互作用:对癌症干性和耐药性转录调控的影响
BMC Cancer. 2025 Aug 20;25(1):1348. doi: 10.1186/s12885-025-14789-3.
6
Linking tumour angiogenesis and tumour immunity.将肿瘤血管生成与肿瘤免疫联系起来。
Nat Rev Immunol. 2025 Aug 14. doi: 10.1038/s41577-025-01211-z.
7
Role and Mechanisms of Angiogenesis in Tumours.肿瘤血管生成的作用及机制
Biology (Basel). 2025 Jun 25;14(7):756. doi: 10.3390/biology14070756.
8
Galectins as Master Regulators of Gastric Cancer Progression.半乳糖凝集素作为胃癌进展的主要调节因子
Cells. 2025 Jul 16;14(14):1090. doi: 10.3390/cells14141090.
9
Construction of a whole-brain panorama for glioma vasculature reveals tumor heterogeneity and blood-brain barrier disruption.构建胶质瘤脉管系统的全脑全景图揭示了肿瘤异质性和血脑屏障破坏。
Sci Adv. 2025 Jul 25;11(30):eadw8330. doi: 10.1126/sciadv.adw8330. Epub 2025 Jul 23.
10
A novel vasculogenic mimicry-related nomogram predicts prognosis in hepatocellular carcinoma.一种新型的血管生成拟态相关列线图可预测肝细胞癌的预后。
Front Genet. 2025 Jul 7;16:1431624. doi: 10.3389/fgene.2025.1431624. eCollection 2025.
Front Oncol. 2019 Sep 27;9:998. doi: 10.3389/fonc.2019.00998. eCollection 2019.
4
Cancer stem-like cells directly participate in vasculogenic mimicry channels in triple-negative breast cancer.癌症干细胞样细胞直接参与三阴性乳腺癌的血管生成拟态通道。
Cancer Biol Med. 2019 May;16(2):299-311. doi: 10.20892/j.issn.2095-3941.2018.0209.
5
Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells.EphA2-磷脂酰肌醇-3-激酶信号传导在胃癌细胞中癌相关成纤维细胞诱导的血管生成拟态中的作用
Oncol Lett. 2019 Sep;18(3):3031-3038. doi: 10.3892/ol.2019.10677. Epub 2019 Jul 26.
6
Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer.载二氢青蒿素紫杉醇联合川芎嗪胶束通过 DQA 修饰抑制非小细胞肺癌转移。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):3465-3477. doi: 10.1080/21691401.2019.1653900.
7
Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis.长链非编码RNA,肿瘤诱导血管生成中新兴且多功能的调节因子。
Am J Cancer Res. 2019 Jul 1;9(7):1367-1381. eCollection 2019.
8
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer.血管生成拟态与曲妥珠单抗耐药的 HER2 阳性乳腺癌相关。
Breast Cancer Res. 2019 Aug 6;21(1):88. doi: 10.1186/s13058-019-1167-3.
9
Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer.靶向阿霉素和薯蓣皂素共载脂质体联合 PFV 修饰抑制非小细胞肺癌转移。
Int J Nanomedicine. 2019 May 31;14:4071-4090. doi: 10.2147/IJN.S194304. eCollection 2019.
10
HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells.低氧微RNA分析鉴定出miR-765是SKOV3卵巢癌细胞中血管生成拟态早期阶段的调节因子。
Front Oncol. 2019 May 14;9:381. doi: 10.3389/fonc.2019.00381. eCollection 2019.